S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
15 A.I. Trading Opportunities a Day (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination

UnitedHealth Group (UNH) Competitors

$481.52
+3.82 (+0.80%)
(As of 05/26/2023 07:00 PM ET)
Compare
Today's Range
$478.00
$488.39
50-Day Range
$466.59
$526.23
52-Week Range
$449.70
$558.10
Volume
3.14 million shs
Average Volume
3.32 million shs
Market Capitalization
$448.31 billion
P/E Ratio
22.02
Dividend Yield
1.37%
Price Target
$601.38

UNH vs. JNJ, LLY, NVO, MRK, ABBV, AZN, PFE, NVS, TMO, and ABT

Should you be buying UnitedHealth Group stock or one of its competitors? The main competitors of UnitedHealth Group include Johnson & Johnson (JNJ), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Merck & Co., Inc. (MRK), AbbVie (ABBV), AstraZeneca (AZN), Pfizer (PFE), Novartis (NVS), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT). These companies are all part of the "medical" sector.

UnitedHealth Group vs.

Johnson & Johnson (NYSE:JNJ) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Johnson & Johnson has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500. Comparatively, UnitedHealth Group has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

Johnson & Johnson pays an annual dividend of $4.76 per share and has a dividend yield of 3.1%. UnitedHealth Group pays an annual dividend of $6.60 per share and has a dividend yield of 1.4%. Johnson & Johnson pays out 99.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. UnitedHealth Group pays out 30.2% of its earnings in the form of a dividend. Johnson & Johnson has raised its dividend for 62 consecutive years and UnitedHealth Group has raised its dividend for 13 consecutive years. Johnson & Johnson is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Johnson & Johnson has a net margin of 13.22% compared to UnitedHealth Group's net margin of 6.16%. Johnson & Johnson's return on equity of 36.13% beat UnitedHealth Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Johnson & Johnson 13.22% 36.13% 14.66%
UnitedHealth Group 6.16% 27.05% 8.68%

UnitedHealth Group received 584 more outperform votes than Johnson & Johnson when rated by MarketBeat users. Likewise, 80.83% of users gave UnitedHealth Group an outperform vote while only 64.84% of users gave Johnson & Johnson an outperform vote.

CompanyUnderperformOutperform
Johnson & JohnsonOutperform Votes
1044
64.84%
Underperform Votes
566
35.16%
UnitedHealth GroupOutperform Votes
1628
80.83%
Underperform Votes
386
19.17%

Johnson & Johnson currently has a consensus target price of $173.00, suggesting a potential upside of 12.08%. UnitedHealth Group has a consensus target price of $601.38, suggesting a potential upside of 24.89%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts clearly believe UnitedHealth Group is more favorable than Johnson & Johnson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Johnson & Johnson
0 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.46
UnitedHealth Group
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
3.00

UnitedHealth Group has higher revenue and earnings than Johnson & Johnson. UnitedHealth Group is trading at a lower price-to-earnings ratio than Johnson & Johnson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson & Johnson$94.94 billion4.22$17.94 billion$4.7832.29
UnitedHealth Group$324.16 billion1.38$20.12 billion$21.8722.02

In the previous week, UnitedHealth Group had 7 more articles in the media than Johnson & Johnson. MarketBeat recorded 21 mentions for UnitedHealth Group and 14 mentions for Johnson & Johnson. UnitedHealth Group's average media sentiment score of 0.68 beat Johnson & Johnson's score of 0.40 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Johnson & Johnson
5 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Neutral
UnitedHealth Group
5 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

67.9% of Johnson & Johnson shares are owned by institutional investors. Comparatively, 86.3% of UnitedHealth Group shares are owned by institutional investors. 0.2% of Johnson & Johnson shares are owned by insiders. Comparatively, 0.4% of UnitedHealth Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

UnitedHealth Group beats Johnson & Johnson on 15 of the 22 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UNH vs. The Competition

MetricUnitedHealth GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$448.31B$67.52B$4.46B$14.41B
Dividend Yield1.37%1.36%6.00%4.08%
P/E Ratio22.0214.1389.2717.40
Price / Sales1.380.563,515.298.92
Price / Cash18.3812.2821.8615.13
Price / Book5.523.164.576.91
Net Income$20.12B$3.18B$115.80M$895.30M
7 Day Performance0.19%-7.46%108.92%-0.90%
1 Month Performance-2.15%-5.07%120.78%-1.35%
1 Year Performance-5.05%-26.72%142.55%-10.16%

UnitedHealth Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JNJ
Johnson & Johnson
2.8025 of 5 stars
$156.81
0.0%
$173.00
+10.3%
-14.8%$407.51B$94.94B32.81155,800
LLY
Eli Lilly and
2.906 of 5 stars
$423.21
-2.5%
$415.75
-1.8%
+31.6%$401.74B$27.69B67.2839,000Analyst Report
NVO
Novo Nordisk A/S
2.6945 of 5 stars
$163.48
-4.1%
$383.33
+134.5%
+51.3%$369.95B$25.06B43.0255,185
MRK
Merck & Co., Inc.
2.854 of 5 stars
$113.27
-1.1%
$120.75
+6.6%
+19.3%$287.42B$59.28B22.1269,000Dividend Announcement
ABBV
AbbVie
2.7332 of 5 stars
$142.52
-1.6%
$163.40
+14.7%
-8.3%$255.65B$56.74B33.6950,000Short Interest ↓
Analyst Revision
AZN
AstraZeneca
2.5014 of 5 stars
$74.07
-0.5%
$126.00
+70.1%
+7.6%$229.59B$44.35B48.7383,500Analyst Report
Options Volume
PFE
Pfizer
3.3362 of 5 stars
$39.64
+2.3%
$47.33
+19.4%
-30.3%$223.78B$100.33B7.8083,000High Trading Volume
NVS
Novartis
1.8861 of 5 stars
$100.25
-0.5%
$82.25
-18.0%
+7.0%$212.49B$50.55B30.85101,703
TMO
Thermo Fisher Scientific
2.677 of 5 stars
$525.10
-0.7%
$627.91
+19.6%
-8.8%$202.54B$44.92B34.23130,000Dividend Announcement
Analyst Revision
ABT
Abbott Laboratories
3.0108 of 5 stars
$105.74
-2.3%
$122.37
+15.7%
-11.8%$183.88B$43.65B32.14115,000Short Interest ↑

Related Companies and Tools

This page (NYSE:UNH) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -